<DOC>
	<DOCNO>NCT02872675</DOCNO>
	<brief_summary>The current study aim explore role prebiotic supplementation adult without Asthma/Exercise-Induced Bronchoconstriction ( A/EIB ) . All participant ask consume prebiotic supplement , placebo , total duration four week , separate four-week wash period . The investigator hypothesise improvement pulmonary function observe follow prebiotic supplementation attribute gut microbiota mediate improvement host immune function .</brief_summary>
	<brief_title>The Effects Prebiotics Gut Bacterial Parameters , Immune Function &amp; Exercise-Induced Airway Inflammation .</brief_title>
	<detailed_description>The current study investigate effect prebiotic base nutritional intervention airway inflammation/bronchoconstriction adult diagnose Asthma/Exercise-Induced Bronchoconstriction ( A/EIB ) . Previous research conduct adult diagnose A/EIB report significant improvement pulmonary function follow three week prebiotic supplementation . The significant improvement pulmonary function attribute attenuation various marker airway inflammation , potentially regulate gut microbiota mediate improvement systemic immune function . Prebiotics type non-digestible carbohydrate/dietary fibre digest certain beneficial bacterial specie . As part prebiotic digestion , beneficial bacteria produce energy/metabolites use support variety human immune function , reduce level airway inflammation occurs follow exposure relevant trigger ( e.g . exercise ) . Imbalances and/or deficiency gut bacterial composition identify adult diagnose long-term allergic asthma . However , potential mechanism behind manipulate gut bacterial composition may lead reduction severity A/EIB yet investigate . Participants without A/EIB allocate two separate nutritional supplement follow randomised , double-blind , placebo-controlled design . During first phase nutritional intervention , participant consume first supplement ( either prebiotic , placebo ) , total duration four week . A four-week wash period complete remain nutritional supplement administer equal duration . Analyses gut bacterial composition , key bacterial metabolite production , carry alongside assessment immune pulmonary function baseline , throughout phase nutritional intervention . As result , data obtain enable role gut microbiota mediate improvement immune function explore . Current understandings role gut microbiota pathogenesis A/EIB expand investigation novel pathophysiological mechanism , help inform future treatment prospect .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Asthma , Exercise-Induced</mesh_term>
	<criteria>Inclusion Criteria To eligible take part , participant must : Be 1850 year age . Have body mass index ( BMI ) 18.525 kg∙m2 ( worked participant use height body mass ) . Be physically active ( complete 3 exercise session week last least 45 minute ) . No smoke history/currently smoke . Asthma/EIB sufferer must current clinically prescribed medication ( e.g . short act β2agonists ) . Exclusion Criteria Unfortunately , participants able take part follow apply : Asthma/EIB sufferer current Asthma/EIB prescription medication . Routine consumption Omega3 polyunsaturated fatty acid supplement , and/or high level habitual Omega3 consumption ( e.g . &gt; 12 portion oily fish week ) . Consumption supplement contain antioxidant . Take daily dose Aspirin nonsteroidal antiinflammatory drug Ibuprofen . Have consume prebiotics and/or probiotic , drug affect gastrointestinal mobility , laxatives 4 week prior participation . Currently take daily dose antihistamine , could refrain 72 hour test session . Unable refrain take Asthma maintenance medication , e.g . standard inhale corticosteroid ( 12 Hours ) , long act inhale corticosteroid ( 24 Hours ) , combine inhaled corticosteroid long act β2agonists therapy ( 24 Hours ) , leukotriene modifier ( 96 Hours ) prior test session . Vegetarian Vegan diet . Previously diagnose Chronic Obstructive Pulmonary Disease ( COPD ) , Emphysema , Chronic Bronchitis , similar Respiratory Illness . Major Asthma Attack within last month ( result course steroid , hospital visit ) . History Heart Failure , Pulmonary Hypertension , Embolism , Pulmonary Heart Disease . History recurrent chest infection . Smoker . Pregnant , plan pregnancy lactating . Had acute infection within last four week . Had major operation within past four month . History gastrointestinal drug reaction . Have take antibiotic past 3 month . History current evidence Gastrointestinal Disease ( e.g . Chronic Constipation , Diarrhoea , Irritable Bowel Syndrome , Chrohn 's Disease ) . Recent participation research project , study , and/or clinical trial may confound effect current study and/or volunteer 's health wellbeing ( please notify chief investigator recent participation ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Exercise-Induced Asthma</keyword>
	<keyword>Gut Bacteria</keyword>
	<keyword>Bimuno® Galactooligosaccharide</keyword>
	<keyword>Pulmonary Function</keyword>
	<keyword>Prebiotics</keyword>
	<keyword>Exercise-Induced Bronchoconstriction</keyword>
	<keyword>Gut Microbiota</keyword>
	<keyword>Nutritional Intervention</keyword>
	<keyword>Eucapnic Voluntary Hyperpnoea</keyword>
	<keyword>Systemic Inflammation</keyword>
	<keyword>Systemic Immune Function</keyword>
	<keyword>Regulatory T Cells</keyword>
	<keyword>TH1 Cells</keyword>
	<keyword>TH2 Cells</keyword>
	<keyword>Short-Chain Fatty Acids</keyword>
	<keyword>Acetate</keyword>
	<keyword>Propionate</keyword>
	<keyword>Butyrate</keyword>
	<keyword>Metagenomics</keyword>
	<keyword>Metabolomics</keyword>
	<keyword>Airway Inflammation</keyword>
</DOC>